Verified peer comparison
AgomAb Therapeutics vs SCHMID Group Financial Comparison
Direct answer
AgomAb Therapeutics and SCHMID Group are compared on the same basis.
The comparison uses 2025 results reported in EUR.
Common metrics include Revenue, Operating income, Net income.
Alpha Vantage
Get free AgomAb Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- AgomAb Therapeutics Revenue
- 0 EUR
- SCHMID Group Revenue
- 64,302,860 EUR
- AgomAb Therapeutics Operating income
- -59,275,000 EUR
- SCHMID Group Operating income
- -9,908,855 EUR